Immunotherapy for cancer is a rapidly developing treatment that modifies the immune
system and enhances the antitumor immune response. B7-H3 (CD276), a member of the B7 …

Abstract B7-H3 (CD276), a member of the B7 family of proteins, is a key player in cancer
progression. This immune checkpoint molecule is selectively expressed in both tumor cells …

Disulfidptosis is a newly discovered form of cell death. Not yet clearly classified as
programmed cell death or accidental cell death. This study aimed to create a novel …

The coinhibitory molecule B7-H4, an important member of the B7 family, is abnormally
expressed in tumors, inflammation and autoimmune diseases. B7-H4 negatively regulates T …

Immune checkpoint inhibitors (ICIs) have shown unprecedented benefits in various adult
cancers, and this success has prompted the exploration of ICI therapy even in childhood …

B7-H3 belongs to the B7 family of immune checkpoint proteins, which are important
regulators of the adaptive immune response and emerging key players in human cancer. B7 …

Abstract B7-H3 (CD276 molecule) is an immune checkpoint from the B7 family of molecules
that acts more as a co-inhibitory molecule to promote tumor progression. It is abnormally …

With the goal of harnessing the host's immune system to provide long-lasting remission and
cures for various cancers, the advent of immunotherapy revolutionized the cancer therapy …

Purpose This study was aimed to investigate the underlying mechanism of B7-H3 induced
ovarian cancer proliferation and drugs resistance. Materials and methods We compared the …

The role of programmed cell death-ligand 1 (PD-L1) in cervical cancer has been widely
investigated; however, the influences of other inhibitory B7 family members are poorly …